Article Text

SAT0561 In Vivo Cartilage-Specific Deletion of Ephrin-B2 in Mice Results in Bone Development Leading to Osteoarthritis Features
  1. G. Valverde-Franco1,
  2. B. Lussier2,
  3. D. Hum1,
  4. J. Wu1,
  5. J.-P. Pelletier1,
  6. M. Kapoor1,
  7. J. Martel-Pelletier1
  1. 1University of Montreal Hospital Research Centre (Crchum), Montreal
  2. 2Faculty of Veterinary Medicine, Clinical Science, University of Montreal, Saint-Hyacinthe, Canada


Background Ephrins and their related receptors have been implicated in mediating developmental events. Our group demonstrated that a member of the ephrin family, ephrin-B2, plays a role in osteoarthritis (OA) knee joint pathology [1–3]. However, we do not yet know the role played by this ephrin in musculoskeletal growth and development.

Objectives This study thus aimed to comprehensively delineate the in vivo role of ephrin-B2 in musculoskeletal growth and development using cartilage-specific ephrin-B2 knockout (ephrin-B2KOcol) mice.

Methods Ephrin-B2KOcol mice were generated by mating collagen II promoter-driven Cre transgenic mice with floxed ephrin-B2 mice (ephrin-B2f/f). The skeletal development of the ephrin-B2KOcol was evaluated using a combination of techniques including macroscopic, histologic, immunohistochemistry, morphometric, radiological, densitometer, and micro-computed tomography (μCT). Analyses were performed on postnatal days (P)0, P15, P21, 8-week and 1-year-old cartilage-specific ephrin-B2KOcol mice, and ephrin-B2f/f littermates were used as controls.

Results Ephrin-B2KOcol mice exhibited reduced size postnatally and at P15 and P21 reduced weight (p<0.01) and length (p<0.01). At 8 weeks, ephrin-B2KOcol mice had significantly shorter femur (p<0.03) and tibia length (p<0.01) and reduced bone mineral density in the total skeleton (p<0.04), femur (p<0.03) and spine (p<0.009). μCT analyses revealed that the distal femur and proximal tibia in ephrin-B2KOcol mice had decreased bone volume (p<0.03) and trabecular thickness (p<0.02), increased trabecular separation (p<0.05), and reduction in mineralized cartilage matrix at the chondro-osseous junction of the growth plate. At 1 year the ephrin-B2KOcol mice demonstrated OA features in both knee and hip. The ephrin-B2KOcol mice exhibited locomotory defects associated with the hip as soon as they walked. Although at 8 weeks the hip of ephrin-B2KOcol mice displayed abnormalities related to a smaller pelvic bone (p<0.01) and canal width (p<0.03), this was not found at 1 year. Moreover, the proximal femoral head with respect to the acetabular parameters did not show major differences, suggesting that the locomotory defect is not due to a developmental hip abnormality.

Conclusions This study was the first to show that in vivo ephrin-B2 is essential for normal bone growth and development and that conditional cartilage-specific ephrin-B2 deficiency leads to significant long bone alterations, dysregulation of mineralization, and OA features.


  1. Kwan Tat, S et al. Arthritis Rheum 2008:58:3820-30.

  2. Kwan Tat, S et al. Arthritis Res Ther 2009:11:R119.

  3. Valverde-Franco, G et al. Arthritis Rheum 2012:64:3614-25.

Disclosure of Interest None declared

DOI 10.1136/annrheumdis-2014-eular.2513

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.